# ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B

> **NCT01633554** · — · UNKNOWN · sponsor: **Turkiye Yuksek Ihtisas Education and Research Hospital** · enrollment: 95 (estimated)

## Conditions studied

- Sequela of Chronic Liver Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01633554
- **Lead sponsor:** Turkiye Yuksek Ihtisas Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-09
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2012-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633554, "ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01633554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*